These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 9170449

  • 1. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, Albin RL, Koeppe RA, Kuhl DE.
    J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [Abstract] [Full Text] [Related]

  • 3. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, Kuhl DE, Schwaiger M.
    J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
    [Abstract] [Full Text] [Related]

  • 4. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
    Mito Y, Yoshida K, Yabe I, Makino K, Hirotani M, Tashiro K, Kikuchi S, Sasaki H.
    Clin Neurol Neurosurg; 2005 Aug; 107(5):396-403. PubMed ID: 16023534
    [Abstract] [Full Text] [Related]

  • 5. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.
    Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE.
    Ann Neurol; 1997 Jul; 42(1):85-94. PubMed ID: 9225689
    [Abstract] [Full Text] [Related]

  • 6. Cerebral glucose metabolism in patients with frontotemporal dementia.
    Ishii K, Sakamoto S, Sasaki M, Kitagaki H, Yamaji S, Hashimoto M, Imamura T, Shimomura T, Hirono N, Mori E.
    J Nucl Med; 1998 Nov; 39(11):1875-8. PubMed ID: 9829574
    [Abstract] [Full Text] [Related]

  • 7. [Cerebral glucose metabolism in Parkinson's disease with dementia].
    Ma AJ, Zhang BS, Pan XD, Gao S, Li ZG.
    Zhonghua Yi Xue Za Zhi; 2008 Oct 14; 88(37):2623-8. PubMed ID: 19080710
    [Abstract] [Full Text] [Related]

  • 8. Early diagnosis of Alzheimer's disease and Parkinson's disease associated with dementia using cerebral perfusion SPECT.
    Song IU, Chung YA, Chung SW, Jeong J.
    Dement Geriatr Cogn Disord; 2014 Oct 14; 37(5-6):276-85. PubMed ID: 24356537
    [Abstract] [Full Text] [Related]

  • 9. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.
    Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE.
    J Nucl Med; 1995 Jul 14; 36(7):1238-48. PubMed ID: 7790950
    [Abstract] [Full Text] [Related]

  • 10. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
    Piert M, Koeppe RA, Giordani B, Minoshima S, Kuhl DE.
    J Nucl Med; 1996 Jul 14; 37(7):1115-22. PubMed ID: 8965180
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P, Furey ML, Graff-Radford N, Freo U, Alexander GE, Grady CL, Dani A, Mentis MJ, Schapiro MB.
    Am J Psychiatry; 1996 Oct 14; 153(10):1261-8. PubMed ID: 8831432
    [Abstract] [Full Text] [Related]

  • 15. Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.
    Castellano CA, Nugent S, Paquet N, Tremblay S, Bocti C, Lacombe G, Imbeault H, Turcotte É, Fulop T, Cunnane SC.
    J Alzheimers Dis; 2015 Oct 14; 43(4):1343-53. PubMed ID: 25147107
    [Abstract] [Full Text] [Related]

  • 16. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
    Arahata Y, Kato T, Tadokoro M, Sobue G.
    Nihon Rinsho; 1997 Jan 14; 55(1):222-6. PubMed ID: 9014454
    [Abstract] [Full Text] [Related]

  • 17. High-resolution PET studies in Alzheimer's disease.
    Kumar A, Schapiro MB, Grady C, Haxby JV, Wagner E, Salerno JA, Friedland RP, Rapoport SI.
    Neuropsychopharmacology; 1991 Jan 14; 4(1):35-46. PubMed ID: 2003867
    [Abstract] [Full Text] [Related]

  • 18. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
    Mielke R, Pietrzyk U, Jacobs A, Fink GR, Ichimiya A, Kessler J, Herholz K, Heiss WD.
    Eur J Nucl Med; 1994 Oct 14; 21(10):1052-60. PubMed ID: 7828614
    [Abstract] [Full Text] [Related]

  • 19. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P, Dani A, Furey ML, Alexander GE, Freo U, Grady CL, Mentis MJ, Mangot D, Simon EW, Horwitz B, Haxby JV, Schapiro MB.
    Am J Psychiatry; 1997 Aug 14; 154(8):1063-9. PubMed ID: 9247390
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.